Editorial Board (编辑委员会委员编): 类似是稿审人的角色,但地位比稿审人高,一般具有一定的学术地位。. 有的期刊编辑会询问编委成员有关期刊发展的建议。. co-editor (合著作者): 一般解释为,除了第一作者和通信作者以外其它作者的统称。. 但有时会针对第二 ...
Computer Engineering Editor-in-chief. Editor-in-chief. Jiang Bo, professorate senior engineer and doctoral supervisor, is the director of East China Institute of Computing Technology(the 32nd Research Institute of China Electronics Technology Group Corporation). He also has the following titles: chairman of the degree evaluation committee of ...
Editorial Board (编辑委员会委员编): 类似是稿审人的角色,但地位比稿审人高,一般具有一定的学术地位。. 有的期刊编辑会询问编委成员有关期刊发展的建议。. co-editor (合著作者): 一般解释为,除了第一作者和通信作者以外其它作者的统称。. 但有时会针对第二 ...
下午4点收到邮件,说editor-in-chief将处理我的文章,晚上12点又收到邮件,说已分配给areaeditor处理。据说好的刊物editor-in-chief也要审的,很多文章直接就被editor-in-chief拒了,不会再分配给areaeditor。这么说我的文章希望很大哦?
Editor-in-Chief Prof. Dr. Niki Pissinou Telecommunications & Information Technology Institute, College of Engineering 评论声明 尊重网上道德,遵守中华人民共和国的各项有关法律法规 承担一切因您的行为而直接或间接导致的民事或刑事法律责任
1.一篇论文投到国际SCI期刊,editor(或ManagingEditor、associateeditor,甚至是editorinchief)会对稿件由一个初步的意见或结论。首先看论文的内容是否符合期刊的定位或scope,比如一篇有关临床的casereport论文投到了JBC,其下场是可以想象的,像 ...
投了国外杂志,状态如下: 5.18 Submit to journal 5.29 editor-in-chief 6.18 assigned reviewer 6.25-7.30 awaiting reviewer scores 7.31-至今Awaiting Editor-in-Chief Decision 这个状态是凶是吉?
Since 1994, he has been the principal investigator of the Division of Antitumor Pharmacology at the Shanghai Institute of Materia Medica. He currently serves as Editor-in-chief of Acta Pharmacologica Sinica and is on the Editorial Board of Eur J Pharmacol, J Ethnopharm and Cancer Biology & Therapy. Areas of Focus. Anti-Tumor Pharmacology.
Editorial Board (编辑委员会委员编): 类似是稿审人的角色,但地位比稿审人高,一般具有一定的学术地位。. 有的期刊编辑会询问编委成员有关期刊发展的建议。. co-editor (合著作者): 一般解释为,除了第一作者和通信作者以外其它作者的统称。. 但有时会针对第二 ...
Computer Engineering Editor-in-chief. Editor-in-chief. Jiang Bo, professorate senior engineer and doctoral supervisor, is the director of East China Institute of Computing Technology(the 32nd Research Institute of China Electronics Technology Group Corporation). He also has the following titles: chairman of the degree evaluation committee of ...
Editorial Board (编辑委员会委员编): 类似是稿审人的角色,但地位比稿审人高,一般具有一定的学术地位。. 有的期刊编辑会询问编委成员有关期刊发展的建议。. co-editor (合著作者): 一般解释为,除了第一作者和通信作者以外其它作者的统称。. 但有时会针对第二 ...
下午4点收到邮件,说editor-in-chief将处理我的文章,晚上12点又收到邮件,说已分配给areaeditor处理。据说好的刊物editor-in-chief也要审的,很多文章直接就被editor-in-chief拒了,不会再分配给areaeditor。这么说我的文章希望很大哦?
Editor-in-Chief Prof. Dr. Niki Pissinou Telecommunications & Information Technology Institute, College of Engineering 评论声明 尊重网上道德,遵守中华人民共和国的各项有关法律法规 承担一切因您的行为而直接或间接导致的民事或刑事法律责任
1.一篇论文投到国际SCI期刊,editor(或ManagingEditor、associateeditor,甚至是editorinchief)会对稿件由一个初步的意见或结论。首先看论文的内容是否符合期刊的定位或scope,比如一篇有关临床的casereport论文投到了JBC,其下场是可以想象的,像 ...
投了国外杂志,状态如下: 5.18 Submit to journal 5.29 editor-in-chief 6.18 assigned reviewer 6.25-7.30 awaiting reviewer scores 7.31-至今Awaiting Editor-in-Chief Decision 这个状态是凶是吉?
Since 1994, he has been the principal investigator of the Division of Antitumor Pharmacology at the Shanghai Institute of Materia Medica. He currently serves as Editor-in-chief of Acta Pharmacologica Sinica and is on the Editorial Board of Eur J Pharmacol, J Ethnopharm and Cancer Biology & Therapy. Areas of Focus. Anti-Tumor Pharmacology.